Table 4.

Significant Independent regression model of cognitive progression through groups of symptoms of behavior disturbance with NPI at first and second stage in patients with AD and FTD.

Regression model	Global	Del.	Hal.	Euph.	Dep.	Anx.	Agg.	Apa.	Dis.	Irr.	Mot. D.	Eat. C.	Sle. P.
(A) AD patients (n = 14)
ΔMoCA (F(1,13) = 3.14, p < 0.05, R2 = 0.41)	β = 0.32 P = 0.10 η2 = 0.06	β = 0.09 P = 0.69 η2 = 0.04	β = 0.19 P = 0.59 η2 = 0.04	β = 0.08 P = 0.65 η2 = 0.03	β = 0.44 P <0.05 η2 = 0.07	β = 0.11 P = 0.63 η2 = 0.04	β = 0.04 P = 0.82 η2 = 0.03	β = 0.23 P = 0.22 η2 = 0.05	β = 0.19 P = 0.59 η2 = 0.04	β = 0.31 P = 0.11 η2 = 0.06	β = 0.08 P = 0.65 η2 = 0.03	β = 0.24 P = 0.21 η2 = 0.05	β = 0.40 P = < 0.05 η2 = 0.06)
(B) FTD patients (n = 14)
ΔMoCA (F(1,13) = 2.41, p < 0.05, R2 = 0.39)	β = 0.15 P = 0.41 η2 = 0.05	β = 0.47 P = <0.05 η2 = 0.07	β = 0.21 P = 0.39 η2 = 0.05	β = 0.09 P = 0.72 η2 = 0.03	β = 0.11 P = 0.47 η2 = 0.04	β = 0.04 P = 0.89 η2 = 0.02	β = 0.17 P = 0.42 η2 = 0.05	β = 0.43 P = <0.05 η2 = 0.05	β = 0.48 P = <0.05 η2 = 0.08	β = 0.19 P = 0.31 η2 = 0.02	β = 0.12 P = 0.47 η2 = 0.02	β = 0.24 P = 0.26 η2 = 0.02	β = 0.22 P = 0.39 η2 = 0.05
ΔMMSE (F(1,13) = 2.19, p < 0.05, R2 = 0.30)	β = 0.23 P = 0.39 η2 = 0.05	β = 0.56 P = <0.05 η2 = 0.06	β = 0.03 P = 0.87 η2 = 0.03	β = 0.26 P = 0.11 η2 = 0.04	β = 0.29 P = 0.18 η2 = 0.05	β = 0.04 P = 0.83 η2 = 0.03	β = 0.26 P = 0.11 η2 = 0.04	β = 0.25 P = 0.12 η2 = 0.04	β = 0.48 P <0.05 η2 = 0.06	β = 0.26 P = 0.11 η2 = 0.04	β = 0.21 P = 0.42 η2 = 0.04	β = 0.11 P = 0.69 η2 = 0.04	β = 0.38 P = 0.21 η2 = 0.05

Note: AD, Alzheimer’s disease; FTD, frontotemporal dementia; NPI, neuropsychiatric inventory; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; Del., delusions; Hal., hallucinations; Euph., euphoria; Dep., depression; Anx., anxiety; Agg., aggression; Apa., apathy; Dis., disinhibition; Irr., irritability; Mot. D., motor disturbance; Eat. C., eating changes; Sle. P., sleep problems.